Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review

C. Appleby, S. Bleiziffer, P. Bramlage, V. Delgado, H. Eltchaninoff, C. Gebhard, C. Hengstenberg, J. Kurucova, P. Marx, TK. Rudolph, W. Wojakowski

. 2024 ; 16 (9) : 6308-6319. [pub] 20240921

Status neindexováno Jazyk angličtina Země Čína

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002446

This state-of-the-art review aimed to synthesize evidence from various sex-stratified studies on aortic stenosis (AS), focusing on the difference in clinical presentation, anatomical characteristics, pathophysiology, and management of AS. In comparison to men, women with AS are present at later stages, are older, more symptomatic, frailer, and exhibit higher operative risk [Society of Thoracic Surgeons (STS) score]. Women tend to have smaller aortic valve (AV) areas and left ventricular (LV) outflow tract, leading to lower stroke volumes (SVs) than men and have a higher prevalence of paradoxical, low-flow, low-gradient AS. In women, chronic pressure overload due to AS results in concentric LV remodelling and hypertrophy, characterized by reduced LV cavities, higher filling pressures, lower wall stress, and more diastolic dysfunction. Conversely, men exhibit more dilated eccentric LV remodelling and hypertrophy. AVs in women are less calcified but more fibrotic. Moreover, women are often underdiagnosed, have severity underestimated, and experience delays or receive fewer referrals for AV replacement (AVR). However, women tend to benefit from transcatheter AVR (TAVR) with a long-term survival advantage over men, although the incidence of vascular complications and bleeding events in 30 days after TAVR is higher in women. Surgical AVR (SAVR) in women has high operative risk, is technically demanding and has poorer outcomes with increased mortality at 30 days compared to men. According to the STS score and EuroSCORE, the female sex itself is considered a risk factor for SAVR. Therefore, addressing sex-related disparities in AS and increasing awareness among physicians promises improved diagnosis and treatment, facilitating equitable care and the development of sex-specific personalized medicine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002446
003      
CZ-PrNML
005      
20250123101932.0
007      
ta
008      
250117s2024 cc f 000 0|eng||
009      
AR
024    7_
$a 10.21037/jtd-24-406 $2 doi
035    __
$a (PubMed)39444914
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a Appleby, Clare $u Department of Cardiology, Liverpool Heart and Chest Hospital, Liverpool, UK
245    10
$a Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review / $c C. Appleby, S. Bleiziffer, P. Bramlage, V. Delgado, H. Eltchaninoff, C. Gebhard, C. Hengstenberg, J. Kurucova, P. Marx, TK. Rudolph, W. Wojakowski
520    9_
$a This state-of-the-art review aimed to synthesize evidence from various sex-stratified studies on aortic stenosis (AS), focusing on the difference in clinical presentation, anatomical characteristics, pathophysiology, and management of AS. In comparison to men, women with AS are present at later stages, are older, more symptomatic, frailer, and exhibit higher operative risk [Society of Thoracic Surgeons (STS) score]. Women tend to have smaller aortic valve (AV) areas and left ventricular (LV) outflow tract, leading to lower stroke volumes (SVs) than men and have a higher prevalence of paradoxical, low-flow, low-gradient AS. In women, chronic pressure overload due to AS results in concentric LV remodelling and hypertrophy, characterized by reduced LV cavities, higher filling pressures, lower wall stress, and more diastolic dysfunction. Conversely, men exhibit more dilated eccentric LV remodelling and hypertrophy. AVs in women are less calcified but more fibrotic. Moreover, women are often underdiagnosed, have severity underestimated, and experience delays or receive fewer referrals for AV replacement (AVR). However, women tend to benefit from transcatheter AVR (TAVR) with a long-term survival advantage over men, although the incidence of vascular complications and bleeding events in 30 days after TAVR is higher in women. Surgical AVR (SAVR) in women has high operative risk, is technically demanding and has poorer outcomes with increased mortality at 30 days compared to men. According to the STS score and EuroSCORE, the female sex itself is considered a risk factor for SAVR. Therefore, addressing sex-related disparities in AS and increasing awareness among physicians promises improved diagnosis and treatment, facilitating equitable care and the development of sex-specific personalized medicine.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bleiziffer, Sabine $u Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital, Ruhr-University Bochum, Bad Oeynhausen, Germany
700    1_
$a Bramlage, Peter $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
700    1_
$a Delgado, Victoria $u Department of Cardiology, Heart Institute, Hospital University Germans Trias i Pujol, Barcelona, Spain
700    1_
$a Eltchaninoff, Helene $u Department of Cardiology, Normandie Univ, UNIROUEN, U1096, CHU Rouen, Rouen, France
700    1_
$a Gebhard, Catherine $u Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Hengstenberg, Christian $u Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria
700    1_
$a Kurucova, Jana $u Edwards Lifesciences, Prague, Czech Republic
700    1_
$a Marx, Philipp $u Edwards Lifesciences, Nyon, Switzerland
700    1_
$a Rudolph, Tanja K $u Department of General and Interventional Cardiology/Angiology, Heart and Diabetes Centre Nordrhine-Westfalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany
700    1_
$a Wojakowski, Wojtek $u Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
773    0_
$w MED00194907 $t Journal of thoracic disease $x 2072-1439 $g Roč. 16, č. 9 (2024), s. 6308-6319
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39444914 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101926 $b ABA008
999    __
$a ok $b bmc $g 2254578 $s 1238449
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 16 $c 9 $d 6308-6319 $e 20240921 $i 2072-1439 $m Journal of thoracic disease $n J Thorac Dis $x MED00194907
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Možnosti archivace